Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kimmo Porkka

Showing results (31-40 of 142) with videos related to

Pageof 15
Sort By:
Leukemia & Lymphoma|April 5, 2018
Case studies investigating genetic heterogeneity between anatomically distinct bone marrow compartments in acute myeloid leukemiaPoojitha N Ojamies, Mika Kontro, Henrik Edgren, et al.
Ejhaem|November 29, 2023
Real-world experience of novel multiple myeloma treatments in a large, single-center cohort in FinlandHeidi Loponen, Juha Mehtälä, Tero Ylisaukko-Oja, et al.
Journal of Pediatric Hematology/Oncology|July 26, 2018
Acute Lymphoblastic Leukemia With INPP5D-ABL1 Fusion Responds to Imatinib TreatmentMarkus Poukka, Tiina Lund-Aho, Päivi Raittinen, et al.
Leukemia|August 9, 2022
An immunity and pyroptosis gene-pair signature predicts overall survival in acute myeloid leukemiaWeikaixin Kong, Liye He, Jie Zhu, et al.
Cancer Cell|December 12, 2003
Progressive vascular changes in a transgenic mouse model of squamous cell carcinomaJason A Hoffman, Enrico Giraudo, Mallika Singh, et al.
Experimental Hematology|June 5, 2012
Phosphoprotein profiling predicts response to tyrosine kinase inhibitor therapy in chronic myeloid leukemia patientsSari E Jalkanen, Anna-Maria Lahesmaa-Korpinen, Caroline A Heckman, et al.
Plos One|January 31, 2017
Early BCR-ABL1 Transcript Decline after 1 Month of Tyrosine Kinase Inhibitor Therapy as an Indicator for Treatment Response in Chronic Myeloid LeukemiaMohamed El Missiry, Henrik Hjorth-Hansen, Johan Richter, et al.
Haematologica|January 29, 2008
Comparison of bone marrow high mitotic index metaphase fluorescence in situ hybridization to peripheral blood and bone marrow real time quantitative polymerase chain reaction on the International Scale for detecting residual disease in chronic myeloid leukemiaTuija Lundán, Vesa Juvonen, Martin C Mueller, et al.
Leukemia|April 11, 2018
Germline alterations in a consecutive series of acute myeloid leukemiaUlla Wartiovaara-Kautto, Elina A M Hirvonen, Esa Pitkänen, et al.
European Journal of Haematology|July 28, 2010
Molecular monitoring and mutation analysis of patients with advanced phase CML and Ph+ ALL receiving dasatinibUlla Olsson-Strömberg, Monica Hermansson, Tuija Lundán, et al.
Pageof 15

Showing results (31-40 of 142) with videos related to

Sort By:
Pageof 15
Leukemia & Lymphoma|April 5, 2018
Case studies investigating genetic heterogeneity between anatomically distinct bone marrow compartments in acute myeloid leukemiaPoojitha N Ojamies, Mika Kontro, Henrik Edgren, et al.
Ejhaem|November 29, 2023
Real-world experience of novel multiple myeloma treatments in a large, single-center cohort in FinlandHeidi Loponen, Juha Mehtälä, Tero Ylisaukko-Oja, et al.
Journal of Pediatric Hematology/Oncology|July 26, 2018
Acute Lymphoblastic Leukemia With INPP5D-ABL1 Fusion Responds to Imatinib TreatmentMarkus Poukka, Tiina Lund-Aho, Päivi Raittinen, et al.
Leukemia|August 9, 2022
An immunity and pyroptosis gene-pair signature predicts overall survival in acute myeloid leukemiaWeikaixin Kong, Liye He, Jie Zhu, et al.
Cancer Cell|December 12, 2003
Progressive vascular changes in a transgenic mouse model of squamous cell carcinomaJason A Hoffman, Enrico Giraudo, Mallika Singh, et al.
Experimental Hematology|June 5, 2012
Phosphoprotein profiling predicts response to tyrosine kinase inhibitor therapy in chronic myeloid leukemia patientsSari E Jalkanen, Anna-Maria Lahesmaa-Korpinen, Caroline A Heckman, et al.
Plos One|January 31, 2017
Early BCR-ABL1 Transcript Decline after 1 Month of Tyrosine Kinase Inhibitor Therapy as an Indicator for Treatment Response in Chronic Myeloid LeukemiaMohamed El Missiry, Henrik Hjorth-Hansen, Johan Richter, et al.
Haematologica|January 29, 2008
Comparison of bone marrow high mitotic index metaphase fluorescence in situ hybridization to peripheral blood and bone marrow real time quantitative polymerase chain reaction on the International Scale for detecting residual disease in chronic myeloid leukemiaTuija Lundán, Vesa Juvonen, Martin C Mueller, et al.
Leukemia|April 11, 2018
Germline alterations in a consecutive series of acute myeloid leukemiaUlla Wartiovaara-Kautto, Elina A M Hirvonen, Esa Pitkänen, et al.
European Journal of Haematology|July 28, 2010
Molecular monitoring and mutation analysis of patients with advanced phase CML and Ph+ ALL receiving dasatinibUlla Olsson-Strömberg, Monica Hermansson, Tuija Lundán, et al.
Pageof 15